Definitive Contract 75F40120C00034
Award Date 4/22/20
Potential Completion Date 9/11/22
Potential Value $611K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Clarivate Analytics (Us) LLC for a one-year license to the Cortellis Clinical Trials Intelligence and Regulatory Intelligence database subscription services. The potential value of the contract is $201,390.00. The solicitation was an open competition, with no set-aside designation. The services will support the FDA's Office of Clinical Pharmacology and its mission to...
- The Department of Health and Human Services Food and Drug Administration awarded a $207,623 purchase order to Clarivate Analytics (Us) LLC for ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION. Under this firm fixed price contract, Clarivate Analytics will provide data acquisition services to the FDA relating to API manufacturers. Performance will take place in Silver Spring, Maryland over approximately one year, from September 2023 through September 2024. As the regulator of...
- This is a $180,000 firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a global provider of scientific and medical research databases and analytics tools. The contract is for data acquisition services related to active pharmaceutical ingredients (APIs), including information on API manufacturing facilities and activities. This single-award contract has a completion date of September 24, 2021....
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for a Clarivate Cortellis Pharmaceutical Database subscription. The potential value of this award is $29,806.14 and the performance period runs through September 18, 2023. Clarivate Analytics provides scientific literature database subscriptions and analytics platforms to various federal agencies,...
- This federal contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a global provider of scientific and technical information and analytics services. The contract, valued at $188,500.00, is for the acquisition of Active Pharmaceutical Ingredients (API) manufacturer data. The contract is a firm fixed price Purchase Order with no set-aside designation. Clarivate Analytics is a prime contractor that has...
- This is a $109,853.26 firm fixed price purchase order awarded by the National Institute on Drug Abuse, a component of the U.S. Department of Health and Human Services, to Clarivate Analytics (Us) LLC. The contract provides a user license and subscription to the OFF-X (Translational Safety/Toxicology) and Cortellis Drug Discovery Intelligence software with the Biomarkers Module for the period of April 1, 2024 through March 31, 2025, with a total contract period of performance through March 31,...
- The Department of Health and Human Services Food and Drug Administration awarded a $2.3 million firm fixed-price contract to Clarivate Analytics (Us) LLC for Biomarker Database Search Solutions supporting and enhancing biomarker qualification. The five-year contract provides continuous access to a well-curated biomarker database and search capabilities to evaluate biomarker drug development tool submissions as requested in the solicitation. Clarivate Analytics will deliver its biomarker...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed-price purchase order to Clarivate Analytics (US) LLC for the Cortellis Deal Intelligence database subscription. The $17,035.60 contract has a completion date of September 29, 2020 and was not set aside for a specific business type. Clarivate Analytics is a global leader in providing subscription-based scientific, technical, medical, and scholarly...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm fixed price purchase order contract to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for a Drug Research Advisor subscription, Off-X (Translational Safety/Toxicology) and Cortellis Drug Discovery Intelligence software with Biomarkers Module. The period of performance is April 1, 2021 to March 31, 2022, with two one-year option periods. The potential...
- The Department of Health and Human Services' Food and Drug Administration awarded a $157,134 firm fixed price delivery order contract to Regan Technologies Corporation. This order is placed against Solutions for Enterprise-Wide Procurement V, a government-wide acquisition contract vehicle, to provide CLC BIO software licenses. The place of performance is Silver Spring, Maryland. The one-year contract begins on September 27, 2023 and concludes on September 29, 2024. As the FDA works to protect...